Successful treatment of Parkinson's disease, accelerated commercialization of brain-machine interfaces, and the lowest fee rate among similar medical device ETFs, Huaxin Wealth (159797), increased by 2.65%.

Today, the A-share market is warming up, with the Shanghai Composite Index surpassing 3,900 points. As of 14:07, the Healthcare Equipment ETF Huitianfu (159797) increased by 2.65%, with the latest price reported at 0.737 yuan and a turnover rate of 0.70%.

The Healthcare Equipment ETF Huitianfu (159797) closely tracks the Healthcare Equipment Index. Among the top ten weighted stocks in the ETF, Mindray Medical rose by 3.17%, United Imaging Healthcare increased by 1.93%, Yuwell Medical grew by 2.04%, New Industries rose by 1.21%, Aimeike increased by 1.85%, Huatai Medical grew by 4.03%, Lepu Medical rose by 3.89%, Furuike Medical increased by 2.16%, Yingke Medical grew by 0.82%, and BGI Genomics rose by 2.74%.

Data shows that the latest fund size of the Healthcare Equipment ETF Huitianfu (159797) has increased by 227 million yuan compared to a year ago.

The commercialization of domestic brain-computer interfaces is accelerating. Recently, in Wuxi, the world’s first invasive brain-computer interface medical device successfully powered on, marking the first case in Wuxi to treat Parkinson’s disease with this groundbreaking device.

In addition, the country’s first brain-controlled rehabilitation training system using “photoelectric dual-modal” decoding technology was also released recently in Wuhan. It is reported that this system has already conducted early clinical studies in several top-tier hospitals, allowing patients to control robotic arms to grasp objects or drive lower limb exoskeletons to walk after a short training period.

On the policy front, the “14th Five-Year” plan outline has been released, listing brain-computer interfaces as one of the six future industries requiring forward-looking layout. Brain-computer interface technology has officially risen to the national strategic level from scientific research exploration, ushering in a period of policy dividends for the industry.

Caixin Securities points out that the healthcare equipment industry is expected to achieve multidimensional development through enterprise technology platforming, AI diagnosis expansion, and breakthroughs in consumer healthcare. The industry will shift from scale expansion to a higher-level development stage, with optimistic prospects for high-quality growth and long-term investment opportunities. Among them, the brain-computer interface industry, as a high-growth sector integrating cutting-edge multidisciplinary technologies, is moving toward a critical stage of large-scale application driven by strong policy support, the implementation of medical insurance reimbursement, and continuous technological breakthroughs.

With strong policy support, AI+ healthcare is rising rapidly. The Healthcare Equipment ETF Huitianfu (159797) combines both pharmaceutical attributes and high-end manufacturing features! It comprehensively covers core areas such as medical devices, in vitro diagnostics, high-value consumables, and low-value consumables.

The management fee rate of the Healthcare Equipment ETF Huitianfu (159797) is 0.15%, the custodial fee rate is 0.05%, and the total expense ratio is 0.2%. Its low fee structure effectively helps investors reduce costs.

The Healthcare Equipment ETF Huitianfu (159797) is also connected off-exchange (017632.OF, 017633.OF).